American Portfolios Advisors’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$23.5K Hold
174
﹤0.01% 2106
2022
Q2
$25.9K Sell
174
-3
-2% -$458 ﹤0.01% 2091
2022
Q1
$30.2K Sell
177
-345
-66% -$58K ﹤0.01% 2142
2021
Q4
$135K Sell
522
-3,958
-88% -$1.08M ﹤0.01% 1366
2021
Q3
$1.22M Sell
4,480
-878
-16% -$279K 0.05% 383
2021
Q2
$1.2M Buy
5,358
+393
+8% +$74.1K 0.05% 390
2021
Q1
$542K Sell
4,965
-8,241
-62% -$875K 0.02% 621
2020
Q4
$1.08M Buy
13,206
+658
+5% +$64.6K 0.06% 324
2020
Q3
$869K Sell
12,548
-270
-2% -$19.4K 0.05% 323
2020
Q2
$855K Buy
12,818
+504
+4% +$25.2K 0.06% 305
2020
Q1
$719K Buy
+12,314
New +$479K 0.06% 281

Other funds holding BNTX

American Portfolios Advisors's BNTX Position: Q3 2022 in Review

American Portfolios Advisors held its BioNTech (BNTX) position steady in Q3 2022 at 174 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

American Portfolios Advisors first reported a position in BNTX in Q1 2020 and has held it in 11 quarters since. The position peaked at $1.22M in Q3 2021. 264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

  • American Portfolios Advisors held 174 shares of BioNTech worth $23.5K as of Q3 2022.
  • American Portfolios Advisors left its BioNTech share count unchanged in Q3 2022.
  • BioNTech made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2106 holding.
  • American Portfolios Advisors first reported a position in BioNTech in Q1 2020 and has held it in 11 quarters since.
  • American Portfolios Advisors's BioNTech position peaked at $1.22M in Q3 2021.
  • 264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.